Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma
NCT04642547
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Molecular Targeted Therapy
Interventions
DRUG:
Lenvatinib and Gefitinib
Sponsor
RenJi Hospital